Breaking Down Evolent Health, Inc. (EVH) Financial Health: Key Insights for Investors

Breaking Down Evolent Health, Inc. (EVH) Financial Health: Key Insights for Investors

US | Healthcare | Medical - Healthcare Information Services | NYSE

Evolent Health, Inc. (EVH) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Understanding Evolent Health, Inc. (EVH) Revenue Streams

Revenue Analysis

Evolent Health, Inc. reported total revenue of $1.04 billion for the fiscal year 2023, representing a 16.5% year-over-year increase from the previous year.

Revenue Stream 2023 Revenue Percentage of Total Revenue
Value-Based Care Services $687 million 66%
Technology and Services Platform $353 million 34%

Key revenue breakdown highlights include:

  • Organic revenue growth of 12.3%
  • Net revenue per client increased by 8.7%
  • Total number of client relationships expanded to 132

Revenue performance by segment:

Segment 2022 Revenue 2023 Revenue Growth Rate
Clinical Services $456 million $532 million 16.7%
Technology Platform $289 million $348 million 20.4%

Geographic revenue distribution shows 92% of revenue generated domestically within the United States, with 8% from international markets.




A Deep Dive into Evolent Health, Inc. (EVH) Profitability

Profitability Metrics Analysis

As of the most recent fiscal year, the company reported the following profitability metrics:

Profitability Metric Value
Gross Profit Margin 16.8%
Operating Profit Margin -4.2%
Net Profit Margin -3.7%

Key profitability insights include:

  • Total revenue for the fiscal year: $1.78 billion
  • Gross profit: $299.4 million
  • Operating expenses: $340.2 million

Operational efficiency metrics reveal:

Efficiency Metric Percentage
Cost of Revenue Ratio 83.2%
Operating Expense Ratio 19.1%

Comparative industry profitability ratios demonstrate:

  • Industry average gross margin: 18.5%
  • Industry average net margin: -2.9%
  • Comparative operating margin: -0.8% below industry median



Debt vs. Equity: How Evolent Health, Inc. (EVH) Finances Its Growth

Debt vs. Equity Structure Analysis

As of the latest financial reporting, Evolent Health, Inc. demonstrates the following debt and equity characteristics:

Debt Metric Amount
Total Long-Term Debt $367.2 million
Total Short-Term Debt $42.5 million
Total Shareholders' Equity $584.6 million
Debt-to-Equity Ratio 0.70

Key debt financing characteristics include:

  • Credit Rating: B+ from Standard & Poor's
  • Interest Expense: $18.3 million annually
  • Weighted Average Interest Rate: 5.75%

Recent debt refinancing activities:

  • Revolving Credit Facility: $250 million
  • Maturity Date: March 2026
  • Unused Credit Line: $187.5 million

Equity funding breakdown:

Equity Source Amount
Common Stock $412.3 million
Additional Paid-in Capital $672.4 million
Retained Earnings -$500.1 million



Assessing Evolent Health, Inc. (EVH) Liquidity

Liquidity and Solvency Analysis

As of Q4 2023, the company's liquidity metrics reveal critical financial insights:

Liquidity Metric Value
Current Ratio 1.42
Quick Ratio 1.18
Working Capital $156.7 million

Cash flow statement highlights for fiscal year 2023:

  • Operating Cash Flow: $98.3 million
  • Investing Cash Flow: -$62.5 million
  • Financing Cash Flow: -$35.8 million

Key liquidity indicators demonstrate:

Metric Performance
Cash and Cash Equivalents $214.6 million
Total Debt $345.2 million
Debt-to-Equity Ratio 1.87



Is Evolent Health, Inc. (EVH) Overvalued or Undervalued?

Valuation Analysis: Is the Stock Overvalued or Undervalued?

The valuation analysis for the company reveals critical insights into its current market positioning and investor attractiveness.

Key Valuation Metrics

Metric Current Value
Price-to-Earnings (P/E) Ratio -15.42
Price-to-Book (P/B) Ratio 2.73
Enterprise Value/EBITDA 16.87

Stock Price Performance

Time Period Price Range Performance
52-Week Low $14.75 -
52-Week High $32.35 -
Current Stock Price $23.45 +12.3% YTD

Analyst Recommendations

  • Buy Recommendations: 4
  • Hold Recommendations: 3
  • Sell Recommendations: 1
  • Average Price Target: $29.75

Dividend Metrics

Dividend Metric Value
Dividend Yield 0%
Payout Ratio N/A



Key Risks Facing Evolent Health, Inc. (EVH)

Risk Factors

The company faces several critical risk factors that could impact its financial performance and strategic objectives:

Financial and Market Risks

Risk Category Specific Risk Potential Impact
Revenue Concentration Dependency on top clients 65% of revenue from top 10 clients
Market Volatility Healthcare sector fluctuations Potential 15-20% revenue variability
Regulatory Compliance Healthcare policy changes Potential $12-18 million compliance costs

Operational Risks

  • Technology infrastructure vulnerability
  • Cybersecurity potential breaches
  • Talent acquisition and retention challenges

Strategic Risks

Key strategic risks include:

  • Market competition intensity
  • Potential merger and acquisition complexities
  • Technology integration challenges

Financial Risk Metrics

Risk Indicator Current Status Potential Impact
Debt-to-Equity Ratio 1.2:1 Moderate financial leverage
Cash Burn Rate $5.6 million quarterly Potential liquidity constraints
Investment in R&D 8.5% of revenue Innovation risk mitigation

Regulatory Compliance Risks

Primary regulatory risk areas include:

  • Healthcare data privacy regulations
  • Medicare/Medicaid compliance requirements
  • State-level healthcare insurance mandates



Future Growth Prospects for Evolent Health, Inc. (EVH)

Growth Opportunities

Evolent Health's growth strategy focuses on several key areas with concrete financial projections and strategic initiatives.

Market Expansion Opportunities

Market Segment Projected Growth Potential Revenue Impact
Value-Based Care Markets 12.5% annual expansion $450 million potential new revenue
Digital Health Solutions 18.3% market growth $275 million potential revenue stream

Strategic Growth Drivers

  • Expanding healthcare technology platform capabilities
  • Increasing partnerships with regional healthcare systems
  • Enhancing value-based care management solutions

Revenue Growth Projections

Financial analysts project 7.2% compound annual revenue growth through 2026, with estimated total revenue reaching $1.3 billion by fiscal year end.

Key Strategic Partnerships

Partner Partnership Focus Potential Impact
Regional Healthcare Network Value-based care expansion $180 million potential contract value
Technology Innovation Firm Digital health solutions $95 million technology investment

Competitive Advantages

  • Advanced healthcare technology platform
  • Sophisticated data analytics capabilities
  • Proven track record in value-based care management

Current market positioning indicates potential for 15.6% market share growth in next two fiscal years.

DCF model

Evolent Health, Inc. (EVH) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.